Corona Vaccination: American drugmakers Pfizer and BioNTech have sought permission from the US drugs regulator Food and Drug Administration for emergency use of the corona vaccine for children aged 5 to 11 years. With this step, about 28 million children of America will be able to get protection from the vaccine. Pfizer said that data in support of this has been submitted to the FDA on their behalf. On the request of the pharmaceutical company, a meeting has been scheduled on October 26, taking immediate steps from the drugs regulator.
Parents in the US are eagerly waiting for the regulators’ decision, which could have a positive impact on their family life and the operation of schools. Its approval depends not only on clinic data, but they also have to ensure whether they can prove to regulators that they are capable of properly manufacturing a new pediatric formulation.
Earlier, the UK approved a single dose of Pfizer BioNTech’s anti-Covid-19 vaccine to all children aged 12 to 15, and most vaccines are being administered in schools. Schools are also helping to provide vaccine doses to children, including through a consent process. Parental approval is required to administer the vaccine to children under 16 years of age.
read this also:
Covid-19: Vaccination of children above 12 years may start soon in India, know who will get the vaccine first
Corona Vaccination: Health Minister Mansukh Mandaviya said – 70 percent of the adult population of the country got the first dose of corona vaccine